Francesca Barone
Chief Tech/Sci/R&D Officer en CANDEL THERAPEUTICS, INC. .
Fortuna: 44 918 $ al 31/03/2024
Cargos activos de Francesca Barone
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| CANDEL THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/11/2020 | - |
Historial de carrera de Francesca Barone
Antiguos cargos conocidos de Francesca Barone.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Senda Biosciences, Inc.
 Senda Biosciences, Inc. BiotechnologyHealth Technology Kintai Therapeutics, Inc. engages in discovering and development of precision enteric medicine. It offers discovery platform, enteric biology and analytics, and precision enteric medicines. The company was founded in 2016 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/05/2019 | 01/11/2020 |
| University of Birmingham | Corporate Officer/Principal | 01/01/2010 | 01/05/2019 |
| Institute of Translational Medicine | Corporate Officer/Principal | - | - |
Formación de Francesca Barone.
| Sapienza University of Rome | Doctorate Degree |
| King's College London | Doctorate Degree |
Estadísticas
Internacional
| Reino Unido | 4 |
| Estados Unidos | 3 |
| Italia | 2 |
Operativa
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectorial
| Consumer Services | 4 |
| Health Technology | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| CANDEL THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Senda Biosciences, Inc.
Senda Biosciences, Inc. BiotechnologyHealth Technology Kintai Therapeutics, Inc. engages in discovering and development of precision enteric medicine. It offers discovery platform, enteric biology and analytics, and precision enteric medicines. The company was founded in 2016 and is headquartered in Cambridge, MA. | Health Technology |
| Institute of Translational Medicine |
- Bolsa de valores
- Insiders
- Francesca Barone
- Experiencia
